Skip to main content
PT-141 Clinic

An editorial reading of the bremelanotide literature — what the RECONNECT trials and the FDA label actually establish about PT-141, with the tolerability story read in full and the community reports kept clearly to one side.

Contact / 09

Contact PT-141 Clinic

Corrections, source suggestions, and editorial correspondence about the bremelanotide record. We offer no medical advice and sell nothing.

Editorial correspondence

Use the form below for editorial matters — a correction, a study we have missed, a citation that needs fixing, or a question about how we have read a source. We read every message and we update the record when the literature warrants it. We are most grateful for pointers to peer-reviewed work that sharpens or corrects what is here.

What we cannot answer is anything clinical. There is no clinic here and no clinicians on call. We cannot advise on whether PT-141 (bremelanotide) is appropriate for any person, cannot recommend a dose, and cannot interpret anyone's medical situation. Those questions belong with a qualified healthcare professional who knows the individual.

What not to send

Please do not send requests to buy, source, or price the compound — we do not sell it, link to sellers, or maintain vendor information, and we cannot help with procurement of any kind. Please do not send personal health details seeking advice; we are not able to act on them and they belong with your clinician, not an editorial inbox. Messages of those two kinds will not receive a substantive reply, because answering them is outside what this project does and what it is able to do responsibly.